The objective of this contract is to provide support for the ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, TB, and hepatitis B virus (HBV). The…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00031
- Awardee
-
Gryphon Scientific, LLC UEI K9MTXN4LNUM4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,646,672
Award facts
- Opportunity
-
- 75N93019Q00003 Solicitation number
- Contract value 94% obligated
-
- $3,646,672.31 Current, with exercised options
- $3,887,150.31 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Sealed Bid
- Pricing
- Time and Materials
- Place of performance
- Takoma Park, MD 20912, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,227 | |
| Funding Only Action | -$2,576 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $799,353 | |
| Exercise an Option | $765,864 | |
| Exercise an Option | $737,425 | |
| Change Order | $65,034 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $649,242 | |
| Original award | $633,557 |
About this award
The National Institute of Allergy and Infectious Diseases awarded a $3.887 million definitive contract to Gryphon Scientific, LLC for ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, tuberculosis, and hepatitis B virus on September 30, 2020, under a total small business set-aside.
The contract covers analysis of chemical structures and therapeutic activity of agents for HIV, TB, and HBV, including development of associated analytical tools (CHEMDB). Place of performance is Takoma Park, MD. The contract was priced on a time and materials basis with an ultimate completion date of September 29, 2025.
Service Contract Inventory data reflects a labor footprint declining from 2.5 FTEs in FY2021 to 2.0 FTEs in FY2024, with corresponding contractor hours of 5,256 hours in FY2021 and 4,097 hours in FY2024. Blended government-paid hourly rates rose from $104.89 per hour in FY2021 to a peak of $142.55 per hour in FY2023, settling at $126.58 per hour in FY2024. In FY2024, approximately 12 percent of contractor hours were subcontracted out to a single subcontractor.
Description
The objective of this contract is to provide support for the ongoing survey of chemical and biological information for potential therapeutic compounds for HIV, TB, and hepatitis B virus (HBV). The resulting information and associated analytical tools
Quick answers
Who was awarded contract 75N93020C00031?
75N93020C00031 was awarded to Gryphon Scientific, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2020.
How much is contract 75N93020C00031 worth?
The government has obligated $3,646,672 on 75N93020C00031. Its potential value, with all options, is $3,887,150.
Was contract 75N93020C00031 competed?
The extent of competition for 75N93020C00031 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award